115P - Immune related adverse events (irAE) and disease response with nivolumab in pre-treated advanced non-small cell lung cancer (NSCLC)

Autor: Connolly, E., Mallesara, G., Nordman, I.
Zdroj: In Annals of Oncology April 2017 28 Supplement 2:ii41-ii42
Databáze: ScienceDirect